Fig. 5From: Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalenceSensitivity analyses: impact of vaccine efficacy: (a) base case analysis, (b) scenario analysis. CC, cervical cancer; GDP, gross domestic product; ICER, incremental cost-effectiveness ratio; ZAR, South African RandBack to article page